Company Filing History:
1 out of 5,094 
1 out of 280 
Years Active: 2021
Title: Fanny Thomas: Innovator in Cancer Stem Cell Research
Introduction
Fanny Thomas is a notable inventor based in Montpellier, France. She has made significant contributions to the field of oncology, particularly in the study of cancer stem cells. Her innovative work has led to the development of a patent that addresses critical aspects of cancer treatment and diagnosis.
Latest Patents
Fanny Thomas holds a patent for her invention titled "Delta133p53beta and delta133p53gamma isoforms are biomarkers of cancer stem cells." This patent focuses on methods for producing cancer stem cells through the overexpression of specific isoforms. It also includes methods for predicting the risk of treatment-induced cancer stem cells in patients undergoing chemotherapy. The invention emphasizes the importance of detecting increases in these isoforms following treatment, which can lead to improved therapeutic strategies.
Career Highlights
Throughout her career, Fanny Thomas has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Université de Montpellier. Her research has been pivotal in advancing the understanding of cancer stem cells and their role in cancer progression and treatment resistance.
Collaborations
Fanny has collaborated with notable colleagues, including Pierre Roux and Nikola Arsic. These partnerships have enriched her research and contributed to the development of innovative solutions in cancer treatment.
Conclusion
Fanny Thomas is a pioneering inventor whose work in cancer stem cell research has the potential to transform oncology. Her contributions through her patent and collaborations highlight her commitment to advancing medical science and improving patient outcomes.